Literature DB >> 10089411

Difference density quality (DDQ): a method to assess the global and local correctness of macromolecular crystal structures.

F van den Akker1, W G Hol.   

Abstract

Methods for the evaluation of the accuracy of crystal structures of proteins and nucleic acids are of general importance for structure-function studies as well as for biotechnological and biomedical research based upon three-dimensional structures of biomacromolecules. The structure-validation program DDQ (difference-density quality) has been developed to complement existing validation procedures. The DDQ method is based on the information present in a difference electron-density map calculated with the water molecules deliberately omitted from the structure-factor calculation. The quality of a crystal structure is reflected in this difference map by (i) the height of solvent peaks occurring at physical chemically reasonable positions with respect to protein and ligand atoms and (ii) the number and height of positive and negative 'shift' peaks next to protein atoms. The higher the solvent peaks and the lower the shift peaks, the better the structure is likely to be. Moreover, extraneous positive density due to an incomplete molecular model is also monitored, since this is another indicator of imperfections in the structure. Automated analysis of these types of features in difference electron densities is used to quantify the local as well as global accuracy of a structure. In the case of proteins, the DDQ structure-validation method is found to be very sensitive to small local errors, to omitted atoms and also to global errors in crystal structure determinations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089411     DOI: 10.1107/S0907444998007161

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  17 in total

1.  A test of enhancing model accuracy in high-throughput crystallography.

Authors:  W Bryan Arendall; Wolfram Tempel; Jane S Richardson; Weihong Zhou; Shuren Wang; Ian W Davis; Zhi-Jie Liu; John P Rose; W Michael Carson; Ming Luo; David C Richardson; Bi-Cheng Wang
Journal:  J Struct Funct Genomics       Date:  2005

2.  Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.

Authors:  Wei Ke; Jared M Sampson; Claudia Ori; Fabio Prati; Sarah M Drawz; Christopher R Bethel; Robert A Bonomo; Focco van den Akker
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

3.  Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.

Authors:  Pius S Padayatti; Anjaneyulu Sheri; Monica A Totir; Marion S Helfand; Marianne P Carey; Vernon E Anderson; Paul R Carey; Christopher R Bethel; Robert A Bonomo; John D Buynak; Focco van den Akker
Journal:  J Am Chem Soc       Date:  2006-10-11       Impact factor: 15.419

4.  The importance of the trans-enamine intermediate as a β-lactamase inhibition strategy probed in inhibitor-resistant SHV β-lactamase variants.

Authors:  Wei Ke; Elizabeth A Rodkey; Jared M Sampson; Marion J Skalweit; Anjaneyulu Sheri; Sundar Ram Reddy Pagadala; Michael D Nottingham; John D Buynak; Robert A Bonomo; Focco van den Akker
Journal:  ChemMedChem       Date:  2012-03-21       Impact factor: 3.466

5.  New tools in MolProbity validation: CaBLAM for CryoEM backbone, UnDowser to rethink "waters," and NGL Viewer to recapture online 3D graphics.

Authors:  Michael G Prisant; Christopher J Williams; Vincent B Chen; Jane S Richardson; David C Richardson
Journal:  Protein Sci       Date:  2019-12-10       Impact factor: 6.725

6.  Domain swapping in the low-similarity isomerase/hydratase superfamily: the crystal structure of rat mitochondrial Delta3, Delta2-enoyl-CoA isomerase.

Authors:  Paul A Hubbard; Wenfeng Yu; Horst Schulz; Jung-Ja P Kim
Journal:  Protein Sci       Date:  2005-05-09       Impact factor: 6.725

7.  Structure of the ArsA ATPase: the catalytic subunit of a heavy metal resistance pump.

Authors:  T Zhou; S Radaev; B P Rosen; D L Gatti
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

8.  Transcarboxylase 5S structures: assembly and catalytic mechanism of a multienzyme complex subunit.

Authors:  Pamela R Hall; Run Zheng; Lizamma Antony; Marianne Pusztai-Carey; Paul R Carey; Vivien C Yee
Journal:  EMBO J       Date:  2004-08-26       Impact factor: 11.598

9.  Transcarboxylase 12S crystal structure: hexamer assembly and substrate binding to a multienzyme core.

Authors:  Pamela R Hall; Yan-Fei Wang; Rosa E Rivera-Hainaj; Xiaojing Zheng; Marianne Pustai-Carey; Paul R Carey; Vivien C Yee
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

10.  Crystal structure of a "nonfoldable" insulin: impaired folding efficiency despite native activity.

Authors:  Ming Liu; Zhu-Li Wan; Ying-Chi Chu; Hassan Aladdin; Birgit Klaproth; Meredith Choquette; Qing-Xin Hua; Robert B Mackin; J Sunil Rao; Pierre De Meyts; Panayotis G Katsoyannis; Peter Arvan; Michael A Weiss
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.